Africa Newborn Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Africa · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$18.5 MnPlaceholder estimate
Estimate 2025$20.5 Mn1.7% of the global market
Projected 2034$51.1 Mn 149.6%Adds $30.6 Mn over 9 forecast years
CAGR 2025–203410.7%Faster than 54% of 173 Medical Devices markets here
Key players5
Africa is 1.72% of the global market.
Among regions, the largest is North America at $567.9 Mn.
Fastest growing: Africa (this report) at 10.7% a year.
Africa ranks 6th of 6 by size among regions.
Market size projection
Africa
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
Value added each year
$30.6 Mn total, 2026–2034
Year-by-year market size, 2024–2034
Newborn Screening Market market size by year, Africa
Year
Market size
Change that year
Since 2025
2024 (estimate)
$18.5 Mn
—
—
2025 (base)
$20.5 Mn
+$2.0 Mn
—
2026 (forecast)
$22.7 Mn
+$2.2 Mn
+10.7%
2027 (forecast)
$25.1 Mn
+$2.4 Mn
+22.5%
2028 (forecast)
$27.8 Mn
+$2.7 Mn
+35.7%
2029 (forecast)
$30.7 Mn
+$3.0 Mn
+50.2%
2030 (forecast)
$34.0 Mn
+$3.3 Mn
+66.2%
2031 (forecast)
$37.7 Mn
+$3.6 Mn
+84%
2032 (forecast)
$41.7 Mn
+$4.0 Mn
+103.7%
2033 (forecast)
$46.2 Mn
+$4.5 Mn
+125.5%
2034 (forecast)
$51.1 Mn
+$4.9 Mn
+149.6%
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Africa Newborn Screening Market Analysis Executive Summary
Newborn screening tests babies shortly after birth for rare but serious conditions such as metabolic, hormone and genetic disorders.
Key segments of the newborn Screening market include test (Dried Blood Spot Tests, Hearing Screening and Pulse Oximetry) and technology (Tandem Mass Spectrometry, Immunoassays and DNA Assays).
Africa Newborn Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Africa Newborn Screening Market Dynamics
Market Growth Drivers
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the newborn Screening market.
Opportunity
Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the newborn Screening market room to grow, especially in emerging markets.
Market Restraints
Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the newborn Screening market.
Competitive Landscape for Newborn Screening Market in Africa
The newborn Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Newborn Screening Market in Africa
Newborn Screening in Africa: rules and payment
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products.[1] In some of the countries we cover here, medical devices are regulated by EDA (Egypt)[2], PPB (Kenya)[3] and SAHPRA (South Africa)[4]. How care is paid for in some of these countries: universal health insurance (Egypt)[5], the SHA (Kenya)[6] and planned National Health Insurance (South Africa)[7].
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how newborn Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Africa.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Test
4.2 By Technology
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Revvity
7.2 Natus Medical
7.3 Trivitron Healthcare
7.4 Bio-Rad Laboratories
7.5 Masimo
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The newborn Screening market can be segmented based on various criteria, including test, technology and end user. Here's a breakdown of the market segmentation
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 18 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Newborn Screening market in Africa?
Placeholder estimate: about $20.5 Mn in 2025, rising to about $51.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Newborn Screening market in Africa growing?
Placeholder estimate: about 10.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Newborn Screening market report cover?
The report splits the market by test (Dried Blood Spot Tests, Hearing Screening, Pulse Oximetry, Genomic Screening), technology (Tandem Mass Spectrometry, Immunoassays, DNA Assays) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Newborn Screening market?
Key players include Revvity, Natus Medical, Trivitron Healthcare, Bio-Rad Laboratories and Masimo Corporation.
What is driving the Newborn Screening market?
Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the newborn Screening market.
Who regulates Newborn Screening in Africa?
The African Medicines Agency (AMA) treaty covers medical devices and diagnostics as well as medicines; national regulators still approve products. Source: African Union, African Medicines Agency treaty. Checked 14 Nov 2026.
How much research is published on Newborn Screening?
PubMed lists 3,809 papers on Newborn Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.